Computed tomography-quantified emphysema distribution is associated with lung function decline

被引:60
作者
Hoesein, Firdaus A. A. Mohamed [1 ]
van Rikxoort, Eva [2 ,3 ]
van Ginneken, Bram [2 ,3 ]
de Jong, Pim A.
Prokop, Mathias [4 ]
Lammers, Jan-Willem J. [1 ]
Zanen, Pieter [1 ]
机构
[1] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Resp Med, NL-3508 GA Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Image Sci Inst, Dept Radiol, NL-3508 GA Utrecht, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Diagnost Image Anal Grp, NL-6525 ED Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands
关键词
Chronic obstructive pulmonary disease; computed tomography; emphysema; lung function decline; smoking; ANTITRYPSIN DEFICIENCY; CT; COPD; SMOKERS; SEGMENTATION; DENSITOMETRY; DENSITY; DISEASE; COHORT; TRIAL;
D O I
10.1183/09031936.00186311
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Emphysema distribution is associated with chronic obstructive pulmonary disease. It is, however, unknown whether computed tomography (CT)-quantified emphysema distribution (upper/lower lobe) is associated with lung function decline in heavy (former) smokers. 587 male participants underwent lung CT and pulmonary function testing at baseline and after a median (interquartile range) follow-up of 2.9 (2.8-3.0) yrs. The lungs were automatically segmented based on anatomically defined lung lobes. Severity of emphysema was automatically quantified per anatomical lung lobe and was expressed as the 15th percentile (Hounsfield unit point below which 15% of the low-attenuation voxels are distributed (Perc15)). The CT-quantified emphysema distribution was based on principal component analysis. Linear mixed models were used to assess the association of emphysema distribution with forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC), FEV1 and FVC decline. Mean +/- SD age was 60.2 +/- 5.4 yrs, mean baseline FEV1/FVC was 71.6 +/- 9.0% and overall mean Perc15 was -908.5 +/- 20.9 HU. Participants with upper lobe-predominant CT-quantified emphysema had a lower FEV1/FVC, FEV1 and FVC after follow-up compared with participants with lower lobe-predominant CT-quantified emphysema (p=0.001), independent of the total extent of CT-quantified emphysema. Heavy (former) smokers with upper lobe-predominant CT-quantified emphysema have a more rapid decrease in lung function than those with lower lobe-predominant CT-quantified emphysema.
引用
收藏
页码:844 / 850
页数:7
相关论文
共 33 条
[11]  
GOULD GA, 1991, EUR RESPIR J, V4, P141
[12]   REGIONAL DISTRIBUTION OF EMPHYSEMA - CORRELATION OF HIGH-RESOLUTION CT WITH PULMONARY-FUNCTION TESTS IN UNSELECTED SMOKERS [J].
GURNEY, JW ;
JONES, KK ;
ROBBINS, RA ;
GOSSMAN, GL ;
NELSON, KJ ;
DAUGHTON, D ;
SPURZEM, JR ;
RENNARD, SI .
RADIOLOGY, 1992, 183 (02) :457-463
[13]   Interobserver variability in the determination of upper lobe-predominant emphysema [J].
Hersh, Craig P. ;
Washko, George R. ;
Jacobson, Francine L. ;
Gill, Ritu ;
Estepar, Raul San Jose ;
Reilly, John J. ;
Silverman, Edwin K. .
CHEST, 2007, 131 (02) :424-431
[14]   CT-quantified emphysema in male heavy smokers: association with lung function decline [J].
Hoesein, Firdaus A. A. Mohamed ;
de Hoop, Bartjan ;
Zanen, Pieter ;
Gietema, Hester ;
Kruitwagen, Cas L. J. J. ;
van Ginneken, Bram ;
Isgum, Ivana ;
Mol, Christian ;
van Klaveren, Rob J. ;
Dijkstra, Akkelies E. ;
Groen, Harry J. M. ;
Boezen, H. Marike ;
Postma, Dirkje S. ;
Prokop, Mathias ;
Lammers, Jan-Willem J. .
THORAX, 2011, 66 (09) :782-787
[15]   MMP12, Lung Function, and COPD in High-Risk Populations [J].
Hunninghake, Gary M. ;
Cho, Michael H. ;
Tesfaigzi, Yohannes ;
Soto-Quiros, Manuel E. ;
Avila, Lydiana ;
Lasky-Su, Jessica ;
Stidley, Chris ;
Melen, Erik ;
Soderhall, Cilla ;
Hallberg, Jenny ;
Kull, Inger ;
Kere, Juha ;
Svartengren, Magnus ;
Pershagen, Goran ;
Wickman, Magnus ;
Lange, Christoph ;
Demeo, Dawn L. ;
Hersh, Craig P. ;
Klanderman, Barbara J. ;
Raby, Benjamin A. ;
Sparrow, David ;
Shapiro, Steven D. ;
Silverman, Edwin K. ;
Litonjua, Augusto A. ;
Weiss, Scott T. ;
Celedon, Juan C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (27) :2599-2608
[16]   Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema [J].
Ito, I ;
Nagai, S ;
Handa, T ;
Muro, S ;
Hirai, T ;
Tsukino, M ;
Mishima, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (11) :1378-1382
[17]  
Joliffe I T, 1992, Stat Methods Med Res, V1, P69, DOI 10.1177/096228029200100105
[18]   Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers [J].
Mair, G. ;
Miller, J. J. ;
McAllister, D. ;
Maclay, J. ;
Connell, M. ;
Murchison, J. T. ;
MacNee, W. .
EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (03) :536-542
[19]   General considerations for lung function testing [J].
Miller, MR ;
Crapo, R ;
Hankinson, J ;
Brusasco, V ;
Burgos, F ;
Casaburi, R ;
Coates, A ;
Enright, P ;
van der Grinten, CPM ;
Gustafsson, P ;
Jensen, R ;
Johnson, DC ;
MacIntyre, N ;
McKay, R ;
Navajas, D ;
Pedersen, OF ;
Pellegrino, R ;
Viegi, G ;
Wanger, J .
EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (01) :153-161
[20]   Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study [J].
Murray, CJL ;
Lopez, AD .
LANCET, 1997, 349 (9064) :1498-1504